These mutations have an impact on ApoE binding preferences toward different lipoprotein classes (49) and on low-density lipoprotein (LDL) receptor binding affinity (50), and these variants are associated with susceptibility to distinct disorders, including Alzheimer's disease (51) or type III hypolipoproteinemia (52). This evidence concerns the gene APOE and Alzheimer disease.